Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

MacroGenics Says TAMARACK Study Data Will Not Be Presented At ASCO Annual Meeting But Co. Intends To Maintain Previously Disclosed Plan To Share Further TAMARACK Interim Data By End Of May

Author: Benzinga Newsdesk | April 03, 2024 04:33pm

Posted In: MGNX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist